This issue of Hypha’s newsletter focusses on accessing the major circulating and excretory metabolites of the drug lorcaserin. In particular we look at scalable mechanisms for obtaining N-carbamoyl glucuronides and N-sulfamate metabolites of drugs containing primary or secondary amino functionalities using lorcaserin as a case study.
Click here for a pdf of the newsletter.
